These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26111262)

  • 1. First Human Study of the Investigational Sedative and Anesthetic Drug AZD3043: A Dose-Escalation Trial to Assess the Safety, Pharmacokinetics, and Efficacy of a 30-Minute Infusion in Healthy Male Volunteers.
    Kalman S; Koch P; Ahlén K; Kanes SJ; Barassin S; Björnsson MA; Norberg Å
    Anesth Analg; 2015 Oct; 121(4):885-893. PubMed ID: 26111262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bolus and Bolus Followed by Infusion Study of AZD3043, an Investigational Intravenous Drug for Sedation and Anesthesia: Safety and Pharmacodynamics in Healthy Male and Female Volunteers.
    Norberg Å; Koch P; Kanes SJ; Björnsson MA; Barassin S; Ahlén K; Kalman S
    Anesth Analg; 2015 Oct; 121(4):894-903. PubMed ID: 26097986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Recirculatory Model for Pharmacokinetics and the Effects on Bispectral Index After Intravenous Infusion of the Sedative and Anesthetic AZD3043 in Healthy Volunteers.
    Björnsson MA; Norberg Å; Kalman S; Simonsson USH
    Anesth Analg; 2015 Oct; 121(4):904-913. PubMed ID: 26097984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a Single Ascending Bolus Dose.
    Struys MMRF; Valk BI; Eleveld DJ; Absalom AR; Meyer P; Meier S; den Daas I; Chou T; van Amsterdam K; Campagna JA; Sweeney SP
    Anesthesiology; 2017 Jul; 127(1):20-35. PubMed ID: 28459733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A first-in-man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM-1 receptor inhibition.
    Cuvier V; Lorch U; Witte S; Olivier A; Gibot S; Delor I; Garaud JJ; Derive M; Salcedo-Magguilli M
    Br J Clin Pharmacol; 2018 Oct; 84(10):2270-2279. PubMed ID: 29885068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase 1c Trial Comparing the Efficacy and Safety of a New Aqueous Formulation of Alphaxalone with Propofol.
    Monagle J; Siu L; Worrell J; Goodchild CS; Serrao JM
    Anesth Analg; 2015 Oct; 121(4):914-924. PubMed ID: 26226029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers.
    Sheng XY; Liang Y; Yang XY; Li LE; Ye X; Zhao X; Cui YM
    Eur J Clin Pharmacol; 2020 Mar; 76(3):383-391. PubMed ID: 31873765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced efficacy of the intravenous anesthetic agent AZD3043 at GABA(A) receptors with β2 (N289M) and β3 (N290M) point-mutations.
    Jonsson Fagerlund M; Sjödin J; Dabrowski MA; Krupp J
    Eur J Pharmacol; 2012 Nov; 694(1-3):13-9. PubMed ID: 23009769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.
    Schüttler J; Eisenried A; Lerch M; Fechner J; Jeleazcov C; Ihmsen H
    Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I, dose-escalation trial evaluating the safety and efficacy of emulsified isoflurane in healthy human volunteers.
    Huang H; Li R; Liu J; Zhang W; Liao T; Yi X
    Anesthesiology; 2014 Mar; 120(3):614-25. PubMed ID: 24162462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTX-019 via 2-min injection or 30-min infusion in healthy subjects.
    Ottoboni T; Lauw M; Keller MR; Cravets M; Manhard K; Clendeninn N; Quart B
    Future Oncol; 2019 Mar; 15(8):865-874. PubMed ID: 30574797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients.
    Iirola T; Aantaa R; Laitio R; Kentala E; Lahtinen M; Wighton A; Garratt C; Ahtola-Sätilä T; Olkkola KT
    Crit Care; 2011; 15(5):R257. PubMed ID: 22030215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AZD-3043: a novel, metabolically labile sedative-hypnotic agent with rapid and predictable emergence from hypnosis.
    Egan TD; Obara S; Jenkins TE; Jaw-Tsai SS; Amagasu S; Cook DR; Steffensen SC; Beattie DT
    Anesthesiology; 2012 Jun; 116(6):1267-77. PubMed ID: 22531340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sedation Effects Produced by a Ciprofol Initial Infusion or Bolus Dose Followed by Continuous Maintenance Infusion in Healthy Subjects: A Phase 1 Trial.
    Hu C; Ou X; Teng Y; Shu S; Wang Y; Zhu X; Kang Y; Miao J
    Adv Ther; 2021 Nov; 38(11):5484-5500. PubMed ID: 34559359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, open-label study of the safety and tolerability of fospropofol for patients requiring intubation and mechanical ventilation in the intensive care unit.
    Candiotti KA; Gan TJ; Young C; Bekker A; Sum-Ping ST; Kahn R; Lebowitz P; Littman JJ
    Anesth Analg; 2011 Sep; 113(3):550-6. PubMed ID: 21596879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of fluorine-substituted phenyl acetate derivatives as ultra-short recovery sedative/hypnotic agents.
    Zhang H; Xu X; Chen Y; Qiu Y; Liu X; Liu BF; Zhang G
    PLoS One; 2014; 9(5):e96518. PubMed ID: 24796695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.